Grace Mann

1.2k total citations · 1 hit paper
11 papers, 215 citations indexed

About

Grace Mann is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Grace Mann has authored 11 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Grace Mann's work include Advanced Breast Cancer Therapies (2 papers), Breast Cancer Treatment Studies (2 papers) and Head and Neck Cancer Studies (2 papers). Grace Mann is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), Breast Cancer Treatment Studies (2 papers) and Head and Neck Cancer Studies (2 papers). Grace Mann collaborates with scholars based in United States, Italy and Belgium. Grace Mann's co-authors include Richard de Boer, Geoffrey J. Lindeman, Nilesh Vasan, Miguel García‐Guzmán, Mohammad Razaq, Frank E. Mott, Mary J. Fidler, Patrick K. Ha, David M. Cognetti and Ann M. Gillenwater and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Grace Mann

10 papers receiving 209 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma

2021 120 citations David M. Cognetti, Jennifer M. Johnson et al. Head & Neck profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grace Mann United States	5	99	92	56	54	52	11	215
Henri Schmidt United States	7	51 0.5×	81 0.9×	110 2.0×	20 0.4×	83 1.6×	16	230
Lintong Yao China	9	70 0.7×	53 0.6×	72 1.3×	40 0.7×	137 2.6×	21	259
Daniel J. Craig United States	8	50 0.5×	96 1.0×	36 0.6×	15 0.3×	51 1.0×	13	191
Joanna Kapeleris Australia	8	117 1.2×	251 2.7×	186 3.3×	55 1.0×	74 1.4×	14	340
Jinzhi Lai China	7	37 0.4×	118 1.3×	70 1.3×	15 0.3×	104 2.0×	17	223
Matthen Mathew United States	8	58 0.6×	165 1.8×	87 1.6×	31 0.6×	130 2.5×	13	321
Meixi Jiang China	5	53 0.5×	140 1.5×	62 1.1×	39 0.7×	125 2.4×	7	319
Camilo Garcia France	3	75 0.8×	147 1.6×	35 0.6×	28 0.5×	57 1.1×	10	238
Anja Brouwer Belgium	5	35 0.4×	149 1.6×	103 1.8×	27 0.5×	68 1.3×	7	226
Derek M. Kohler Canada	8	135 1.4×	134 1.5×	106 1.9×	17 0.3×	139 2.7×	10	293

Countries citing papers authored by Grace Mann

Since Specialization

Citations

This map shows the geographic impact of Grace Mann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Mann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Mann more than expected).

Fields of papers citing papers by Grace Mann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Mann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Mann. The network helps show where Grace Mann may publish in the future.

Co-authorship network of co-authors of Grace Mann

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Mann. A scholar is included among the top collaborators of Grace Mann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Mann. Grace Mann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Colombo, Nicoletta, Toon Van Gorp, Ursula A. Matulonis, et al.. (2023). Abstract 3434: Selective glucocorticoid receptor modulation reveals a new role for CLEC10A in patients with solid tumors. Cancer Research. 83(7_Supplement). 3434–3434. 1 indexed citations

Morris, Michael J., Mark Linch, Simon J. Crabb, et al.. (2023). Phase 1 efficacy and pharmacodynamic results of exicorilant + enzalutamide in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 41(6_suppl). 145–145. 3 indexed citations

Cognetti, David M., Jennifer M. Johnson, Joseph Curry, et al.. (2021). Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma. Head & Neck. 43(12). 3875–3887. 120 indexed citations breakdown →

Gillenwater, Ann M., Jennifer M. Johnson, Joseph Curry, et al.. (2020). Survival Following Photoimmunotherapy in Patients (Pts) with Recurrent Head and Neck Squamous Cell Carcinoma (rHNSCC). International Journal of Radiation Oncology*Biology*Physics. 106(5). 1180–1180. 2 indexed citations

Ulaner, Gary A., Cristina Saura, Sarina A. Piha‐Paul, et al.. (2019). Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib. Clinical Cancer Research. 25(24). 7381–7387. 14 indexed citations

Boer, Richard de, et al.. (2018). Spotlight on the utility of the Oncotype DX<sup>®</sup> breast cancer assay. International Journal of Women s Health. Volume 10. 89–100. 42 indexed citations

Jongen, Lynn, Giuseppe Floris, Bram Boeckx, et al.. (2018). Identification, clinical-pathological characteristics and treatment outcomes of patients with metastatic breast cancer and somatic human epidermal growth factor receptor 2 (ERBB2) mutations. Breast Cancer Research and Treatment. 174(1). 55–63. 2 indexed citations

McLeod, David G., George W. Adams, Marc Gittleman, et al.. (2013). Phase I dose escalation trial of MVA-BN-PRO in men with nonmetastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 31(6_suppl). 193–193.

Cutsem, Eric Van, Wu‐Chou Su, J. Wade Davis, et al.. (2010). 408 Phase 2 study of XL184 (BMS-907351) in a cohort of patients (pts) with hepatocellular carcinoma (HCC). European Journal of Cancer Supplements. 8(7). 129–130. 3 indexed citations

10.

Richards, Jon, Alessandro Testori, Eric D. Whitman, et al.. (2006). Autologous tumor-derived HSPPC-96 vs. physician’s choice (PC) in a randomized phase III trial in stage IV melanoma. Journal of Clinical Oncology. 24(18_suppl). 8002–8002. 13 indexed citations

11.

Marcom, P. Kelly, Claudine Isaacs, A. Kommareddy, et al.. (2005). A phase II trial of letrozole and trastuzumab for ER and/or PgR and HER2 positive metastatic breast cancer: Final results. Journal of Clinical Oncology. 23(16_suppl). 596–596. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact